老年男性的丸激素治疗:最近的里程碑性试验的临床影响
Mathis Grossmann1,2, Bradley D Anawalt3, Bu B Yeap4,5
1Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria 3084, Australia.
European journal of endocrinology
|June 25, 2024
概括
丸激素疗法对患有阴性腺体缺陷症的男性提供了适度的好处,改善了能量,情绪和性功能. 它还有助于控制2型糖尿病和肌肉力量,而不会显著增加心血管或前列腺癌的风险.
科学领域:
- 内分泌学 在内分泌学.
- 男人的健康 男人的健康
- 老年学是一门学科.
背景情况:
- 没有明显的下丘脑 - 垂体 - 丸 (HPT) 轴病理的男性的性质下降症在丸激素治疗方面存在不确定的风险和益处.
- 以前的理解缺乏关于在这个特定患者群体的影响的全面数据.
研究的目的:
- 评估丸激素治疗对中年和老年男性的益处和风险,这些男性患有阴性双胞胎症症状和低丸激素水平,但没有确定的HPT病理.
- 为临床决策提供基于证据的见解,关于在男性水平低于正常水平的男性中使用.
主要方法:
- 进行了具有里程碑意义的安慰剂对照试验,涉及中年和老年男性.
- 评估结果包括自我报告的能量,情绪,性功能,2型糖尿病 (T2D) 发病率,肌肉强度,骨密度,骨折和主要心血管不良事件 (MACE).
- 包括血清丸激素度低或低于正常水平的男性,以及低阴性恋或雄激素缺乏症的症状/迹象,不包括HPT病理.
主要成果:
- 激素治疗对自我报告的能量,情绪和性功能产生了适度的好处.
- 结合生活方式的改变,它减少或逆转发生的2型糖尿病 (T2D).
- 观察到肌肉强度和骨密度的适度改善,但没有减少跌倒或骨质疏松性骨折;意外地增加了与创伤相关的骨折.
- 没有发现心肌梗塞,中风或前列腺癌风险的显著增加.
结论:
- 丸激素疗法在男性患有低腺体和低丸激素的特定症状和疾病方面提供了临床上显著的益处,即使没有确定的HPT病理.
- 该疗法在主要心血管事件和前列腺癌方面表现出良好的安全性,但建议对骨折保持谨慎.
- 这些发现提供了关键的数据,以指导在男性出现雄激素缺乏症症状时适当使用丸激素治疗.
更多相关视频
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
12.6K
11:51Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
15.1K
相关概念视频
Disorders of the Male Reproductive System
386
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
386
Testosterone: Functions and Regulation
620
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
620
Menopause
154
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
154
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Signs of Puberty
318
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
318
